HUMAN GENOME SCI (NASDAQ:HGSI)

27.06

-0 (-0%)

HUMAN GENOME SCI (NASDAQ:HGSI) Delayed :
Previous Close	$27.06	52 Week High	$32.07
Open	$26.12	52 Week Low	$0.45
Day High	$27.19	P/E	N/A
Day Low	$26.06	EPS	$-0.36
Volume	4,295,657
More HGSI Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
GSK	18	GSK	7
CIT	7	VRTX	4
DNDN	4	BCRX	3
LTON	3	CPST	3
SNIC	3	HEB	3
AMGN	3	AMLN	3

View All Entities

Nov 30, 2009 04:04 PM Human Genome Sciences (HGSI) To Offer Up to 12.5M Shares
Nov 2, 2009 06:51 AM Human Genome (HGSI) and GlaxoSmithKline Announced That BENLYSTA Met the Primary Endpoint in Second Phase 3 Trial
Oct 29, 2009 04:09 PM Human Genome Sciences Inc. (HGSI) Reports Q3 Loss of $0.32

Jan 27, 2010 08:03 AM RBC Capital Initiates Coverage on Human Genome Sciences (HGSI) with an Outperform
Jan 12, 2010 01:24 PM Human Genome (HGSI) February volatility at 47, April at 53
Jan 11, 2010 08:21 AM BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
Dec 21, 2009 10:46 AM Notable Analyst Rating Changes 12/21: INTC, MU, AA, DKS, PALM Upgraded; JAV, GENZ, NOK, GPS Downgraded
Dec 21, 2009 08:43 AM Human Genome (HGSI) Shares Rising as Morgan Stanley Starts at Overweight

Feb 5, 2010 08:00AM Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO Investor Conference
Feb 1, 2010 08:00AM Benlysta Will Garner Sales of More Than $500 Million in 2018 in the Systemic Lupus Erythematosus Drug Market
Feb 1, 2010 07:00AM Human Genome Sciences Names Scott Habig Vice President, Sales
Jan 26, 2010 08:30AM Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
Jan 11, 2010 07:30AM BioCentury Publishes Investor Picks for New Biotech Bellwethers in 2010

Feb 5, 2010 03:53 PM Friday Options Recap: Defensive Trading
Feb 3, 2010 07:06 AM 3 Best Hedge Fund Healthcare Ideas
Jan 21, 2010 07:13 AM Will Generex Biotech Be Next to Join the Winner's Circle?
Jan 20, 2010 01:11 PM Wednesday Options Update: VIX, HGSI, CREE, CYD & BAC
Jan 18, 2010 05:00 AM Review of My Recent Sales

Feb 4, 2010 11:52AM Form 4 HUMAN GENOME SCIENCES For: Feb 03 Filed by: DAVIS JAMES H
Feb 4, 2010 11:52AM Form 4 HUMAN GENOME SCIENCES For: Feb 03 Filed by: BARABE TIMOTHY C
Feb 2, 2010 05:18PM Form 4 HUMAN GENOME SCIENCES For: Feb 02 Filed by: STUMP DAVID C
Feb 2, 2010 10:08AM Form 4 HUMAN GENOME SCIENCES For: Feb 01 Filed by: Bateson Susan D.
Jan 29, 2010 02:52PM Form SC 13G HUMAN GENOME SCIENCES Filed by: BlackRock Inc.

Donna
on Oct 20, 2009
at 09:25 AM clinical trials How do you get into clinical trials? dmhc24@aol.com
Article: Human Genome (HGSI) and Glaxo (GSK) Announce BLISS-52 Lupus Treatment Results
Adel
on Oct 15, 2009
at 12:26 PM HGSI BUY will get approved on lupus and go thru roof!
Article: Goldman Sachs Resumes Human Genome Sciences (HGSI) at Buy, Sees As Potential Takeover Target
James
on Jul 20, 2009
at 12:50 PM Why vaselate? Your investment professionals could command a greater measure of respect if they would simply issue a statement acknowledging the bad call made on HGSI instead of switching to the buy side after the stock has moved up 193 percent. I understand the difficulties following a difficult stock like HGSI, however, I do not understand the way investment opinions are haphazardly published by your company.
Article: Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
mike
on Jun 5, 2009
at 02:06 PM hgsi it's time to add hgsi to your long portfolio NOW before it is too late....buy it TODAY on the dip...
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds
Kmac
on Jun 5, 2009
at 02:00 PM Analysts Seriously, isn't now the time in financial history to do away with analysts?
Article: ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds

View All Comments

No comments are currently available.